16.7% YTD return hails Fidelity European Trust’s strong credentials

Fidelity

Fidelity European Trust PLC (LON:FEV) monthly factsheet for June 2025.

Portfolio Manager Commentary

Continental European equities ended the month slightly lower (in euro terms) following a strong year-to-date performance. Investor sentiment was impacted by geopolitical uncertainty, particularly towards the end of the month, amid the Israel-Iran conflict, while trade tensions continued to weigh on risk appetite ahead of the 9 July deadline for US trade negotiations. 

The Trust underperformed the index during the month, mainly due to weak stock selection in industrials, technology, and healthcare, though overall sector positioning had a small positive impact. Flavours & fragrances business Symrise was the largest detractor over the period, with shares falling on concerns of a Q2 slowdown driven by macroeconomic headwinds. Shares in Nestlé were weak following the announcement of Chairman Paul Bulke’s planned departure in April 2026 amidst ongoing pressures from subdued consumer demand and rising input costs. In contrast, Legrand shares continued to deliver strong performance underpinned by its strong Q1 2025 results announced in May. The holding in EQT also performed well supported by multiple broker upgrades. 

Our focus is on finding attractively valued companies with good prospects for cash generation and dividend growth over the longer term. On a rolling 12-month basis, the Trust recorded NAV and share price returns of 2.3% and 5.5% respectively, compared to FTSE World Europe ex UK Total Return Index that returned 9.9%.  

Fidelity European Trust PLC (LON:FEV) aims to be the cornerstone long-term investment of choice for those seeking European exposure across market cycles.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Capture growth investment opportunities in Europe in 2026

Portfolio managers Sam Morse and Marcel Stötzel outline why they continue to see opportunity in Europe in 2026.

European stocks climb as defence takes centre stage in investor positioning

European stocks climb as investors rotate into defence, responding decisively to rising geopolitical risk.

European Investment Trust performance boosted by Roche drug trial success (LON: FEV)

Continental European markets delivered positive returns in November. Fidelity European Trust saw encouraging contributions from Roche and ABN AMRO and remains positioned for long-term growth through disciplined stock selection and a focus on sustainable cash flows.

European equities hold ground ahead of policy shifts

European equities edge up as investors navigate a week of policy signals and key data with deliberate caution.

European defence stocks climb on German procurement momentum

Germany’s military procurement plans have kicked defence stocks into motion, giving investors a clearer signal on where the capital is headed.

Fidelity European Trust rose in October with chipmaker ASML top contributor

Fidelity European Trust reported several positives in October, with strong contributions from ASML and Assa Abloy following solid Q3 updates and resilient demand in key areas.

Search

Search